- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 161
Lepu Biotech leaps to $186m series B
Lepu Medical's immuno-oncology spinoff secured $186m in a round co-led by Ping An Capital and the Sunshine Insurance-backed Riverhead Capital.
Aug 6, 2020ChargePoint chases down another $127m
American Electric Power and Chevron Technology Ventures were among the existing investors that helped the EV charging service boost its overall funding to $667m.
Aug 6, 2020Tencent helps slip $358m to Yipin Fresh
The 24-hour grocery chain secured the money in a series C round co-led by Tencent, the corporate investor that also led its series B early last year.
Aug 5, 2020FBN pulls up $250m in series F round
Business optimisation platform developer Farmer’s Business Network was reportedly valued at $1.75bn in the round, which included long-term backer GV.
Aug 4, 2020Xiaopeng expects to raise another $300m
The electric vehicle producer is adding $300m to an initial $500m in series C-plus funding as the Alibaba, Foxconn, UCar and Xiaomi-backed company gears up for a US listing.
Aug 3, 2020Tongcheng Life links up with Linlinyi
Bertelsmann, Joyy and Tencent-backed group buying platform Tongcheng Life has joined forces with Suning-backed peer Lininlyi in a deal that involved a nine-figure dollar investment.
Aug 3, 2020Auto1 parks $300m in its account
The SoftBank-backed automotive e-commerce company secured convertible note financing in a round co-led by Farallon Capital Management and Baupost Group.
Aug 3, 2020Stic Investments to kick $200m over to Grab
The private equity firm will join investors in the on-demand ride service including SoftBank, Toyota, Hyundai, Kia, Qunar, Booking.com, Central Group, Yamaha, Microsoft, Didi and Ping An.
Aug 3, 2020Cerevel seeks reverse merger
Cerevel Therapeutics, co-founded by Pfizer, is set to undertake a reverse merger with Nasdaq-listed Arya II in a deal that will give Cerevel a market cap of $1.3bn.
Jul 31, 2020Thrive prospers with $257m round
Thrive Earlier Detection, the developer of an early cancer screening blood test invented at JHU and backed by Exact Sciences and Blue Cross and Blue Shield Association, has raised $257m in series B funding.
Jul 30, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


